These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 25930117)
1. Increasing Vero viable cell densities for yellow fever virus production in stirred-tank bioreactors using serum-free medium. Mattos DA; Silva MV; Gaspar LP; Castilho LR Vaccine; 2015 Aug; 33(35):4288-91. PubMed ID: 25930117 [TBL] [Abstract][Full Text] [Related]
2. Production of yellow fever virus in microcarrier-based Vero cell cultures. Souza MC; Freire MS; Schulze EA; Gaspar LP; Castilho LR Vaccine; 2009 Oct; 27(46):6420-3. PubMed ID: 19559120 [TBL] [Abstract][Full Text] [Related]
3. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions. Rourou S; van der Ark A; van der Velden T; Kallel H Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281 [TBL] [Abstract][Full Text] [Related]
4. A novel animal-component-free medium for rabies virus production in Vero cells grown on Cytodex 1 microcarriers in a stirred bioreactor. Rourou S; van der Ark A; Majoul S; Trabelsi K; van der Velden T; Kallel H Appl Microbiol Biotechnol; 2009 Nov; 85(1):53-63. PubMed ID: 19521697 [TBL] [Abstract][Full Text] [Related]
5. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media. Genzel Y; Olmer RM; Schäfer B; Reichl U Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022 [TBL] [Abstract][Full Text] [Related]
6. An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures. Pereira RC; Silva AN; Souza MC; Silva MV; Neves PP; Silva AA; Matos DD; Herrera MA; Yamamura AM; Freire MS; Gaspar LP; Caride E Vaccine; 2015 Aug; 33(35):4261-8. PubMed ID: 25862300 [TBL] [Abstract][Full Text] [Related]
7. Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media. Rourou S; Ben Zakkour M; Kallel H Vaccine; 2019 Nov; 37(47):6987-6995. PubMed ID: 31201054 [TBL] [Abstract][Full Text] [Related]
8. Serum-free influenza virus production avoiding washing steps and medium exchange in large-scale microcarrier culture. Genzel Y; Fischer M; Reichl U Vaccine; 2006 Apr; 24(16):3261-72. PubMed ID: 16472544 [TBL] [Abstract][Full Text] [Related]
9. Suspension-Vero cell cultures as a platform for viral vaccine production. Paillet C; Forno G; Kratje R; Etcheverrigaray M Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123 [TBL] [Abstract][Full Text] [Related]
10. Production of Newcastle disease virus by Vero cells grown on cytodex 1 microcarriers in a 2-litre stirred tank bioreactor. Arifin MA; Mel M; Abdul Karim MI; Ideris A J Biomed Biotechnol; 2010; 2010():586363. PubMed ID: 20625497 [TBL] [Abstract][Full Text] [Related]
11. Studies on high-density cultivation of Vero cells with biosilon solid microcarrier. Wang D; Xiao C; Chen Z; Huang Z Chin J Biotechnol; 1996; 12(2):119-29. PubMed ID: 8988358 [TBL] [Abstract][Full Text] [Related]
12. Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development. Wu SC; Liu CC; Lian WC Vaccine; 2004 Sep; 22(29-30):3858-64. PubMed ID: 15364432 [TBL] [Abstract][Full Text] [Related]
13. Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods. Thomassen YE; Rubingh O; Wijffels RH; van der Pol LA; Bakker WA Vaccine; 2014 May; 32(24):2782-8. PubMed ID: 24583004 [TBL] [Abstract][Full Text] [Related]
14. A novel process for production of hepatitis A virus in Vero cells grown on microcarriers in bioreactor. Sun MB; Jiang YJ; Li WD; Li PZ; Li GL; Jiang SD; Liao GY World J Gastroenterol; 2004 Sep; 10(17):2571-3. PubMed ID: 15300909 [TBL] [Abstract][Full Text] [Related]
15. Japanese encephalitis virus production in Vero cells with serum-free medium using a novel oscillating bioreactor. Toriniwa H; Komiya T Biologicals; 2007 Oct; 35(4):221-6. PubMed ID: 17400474 [TBL] [Abstract][Full Text] [Related]
16. Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production. Nikolay A; Léon A; Schwamborn K; Genzel Y; Reichl U Appl Microbiol Biotechnol; 2018 Oct; 102(20):8725-8737. PubMed ID: 30091043 [TBL] [Abstract][Full Text] [Related]
17. Establishment of a mink enteritis vaccine production process in stirred-tank reactor and Wave Bioreactor microcarrier culture in 1-10 L scale. Hundt B; Best C; Schlawin N; Kassner H; Genzel Y; Reichl U Vaccine; 2007 May; 25(20):3987-95. PubMed ID: 17391818 [TBL] [Abstract][Full Text] [Related]
18. High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture. Liu CC; Lian WC; Butler M; Wu SC Vaccine; 2007 Jan; 25(1):19-24. PubMed ID: 16919374 [TBL] [Abstract][Full Text] [Related]
19. Serum-free microcarrier based production of replication deficient influenza vaccine candidate virus lacking NS1 using Vero cells. Chen A; Poh SL; Dietzsch C; Roethl E; Yan ML; Ng SK BMC Biotechnol; 2011 Aug; 11():81. PubMed ID: 21835017 [TBL] [Abstract][Full Text] [Related]
20. Mosquito and mammalian cells grown on microcarriers for four-serotype dengue virus production: variations in virus titer, plaque morphology, and replication rate. Liu CC; Wu SC Biotechnol Bioeng; 2004 Mar; 85(5):482-8. PubMed ID: 14760688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]